LONDON, May 8 (Reuters) - Takeda Pharma agreed tobuy London-listed Shire for 46 billion pounds ($62.42billion) on Tuesday after the Japenese company raised the amountof cash in its offer to $30.33 to secure a recommendation.
Under the terms of the deal, Shire investors will receive$30.33 in cash and either 0.839 new Takeda shares or 1.678Takeda ADSs for each share, the companies said.
Shire shareholders will own about half of the combined groupafter the deal, which will be the biggest in the sector since2000 if approved by shareholders.
($1 = 0.7369 pounds)(Reporting by Paul Sandle; editing by Kate Holton)